bupivacaine(intraperitoneally) — Competitive Intelligence Brief

bupivacaine(intraperitoneally) (bupivacaine(intraperitoneally)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (amide class). Area: Anesthesia / Pain Management.

marketed Local anesthetic (amide class) Voltage-gated sodium channels Anesthesia / Pain Management Small molecule

Target snapshot

bupivacaine(intraperitoneally) (bupivacaine(intraperitoneally)) — Ain Shams University. Bupivacaine blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials to produce local anesthesia.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
bupivacaine(intraperitoneally) TARGET	bupivacaine(intraperitoneally)	Ain Shams University	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels
Levobupivacaine epidural bolus	Levobupivacaine epidural bolus	University of Genova	marketed	Local anesthetic (amino amide)	Voltage-gated sodium channels
Levobupivacaine PCA group	Levobupivacaine PCA group	Osijek University Hospital	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Levobupivacaine with epinephrine	Levobupivacaine with epinephrine	Pontificia Universidad Catolica de Chile	marketed	Local anesthetic with vasoconstrictor	Voltage-gated sodium channels; alpha-1 adrenergic receptors (epinephrine component)
Lidocaine Ropivacaine	Lidocaine Ropivacaine	TriHealth Inc.	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels
IP Lignocaine bolus and infusion	IP Lignocaine bolus and infusion	University of Auckland, New Zealand	marketed	Local anesthetic / Antiarrhythmic agent	Voltage-gated sodium channels
Prilocaine (Hyperbaric 2%)	Prilocaine (Hyperbaric 2%)	Guy's and St Thomas' NHS Foundation Trust	marketed	Local anesthetic	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (amide class) class)

1. Ain Shams University · 2 drugs in this class
2. Başakşehir Çam & Sakura City Hospital · 2 drugs in this class
3. TriHealth Inc. · 2 drugs in this class
4. Centre of Postgraduate Medical Education · 2 drugs in this class
5. Bozyaka Training and Research Hospital · 2 drugs in this class
6. Complejo Hospitalario Universitario de Granada · 1 drug in this class
7. Clinique Saint-Jean, Bruxelles · 1 drug in this class
8. Hospital Clínico Universitario de Valencia · 1 drug in this class
9. Fundacion Clinica Valle del Lili · 1 drug in this class
10. Federal University of Minas Gerais · 1 drug in this class